Search research articles
Contact Us
Filters
Showing results (191-200 of 225) with videos related to
Page
of 23
Sort By:
The Pharmacogenomics Journal
|
April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent
F Aminkeng, C J D Ross, S R Rassekh, et al.
Archives of Women'S Mental Health
|
July 7, 2021
A cross-sectional study of the relationship between CYP2D6 and CYP2C19 variations and depression symptoms, for women taking SSRIs during pregnancy
Catriona Hippman, Caitlin Slomp, Emily Morris, et al.
Human Gene Therapy
|
May 24, 2006
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation
Colin J D Ross, Jaap Twisk, Andrew C Bakker, et al.
Nature Genetics
|
November 10, 2009
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
Colin J D Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2025
Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin Chemotherapy
Joshua Millstein, Shahrad R Rassekh, Austin L Brown, et al.
Gene Therapy
|
March 27, 2025
Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application
Neel Mehta, Rénald Gilbert, Parminder S Chahal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 12, 2026
Liposomal lipid nanoparticles containing dihydrosphingomyelin exhibit improved stability and extended hepatic and extrahepatic transfection
Suiyang Liao, Kevin Fox, Alexandra Birkenshaw, et al.
Canadian Journal of Kidney Health and Disease
|
March 9, 2017
Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study
Kelly R McMahon, Shahrad Rod Rassekh, Kirk R Schultz, et al.
Pediatric Blood & Cancer
|
February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children
H Visscher, C J D Ross, S R Rassekh, et al.
Neurobiology of Disease
|
August 11, 2006
Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma
Braydon L Burgess, Sean A McIsaac, Kathryn E Naus, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 225) with videos related to
Sort By:
Page
of 23
The Pharmacogenomics Journal
|
April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent
F Aminkeng, C J D Ross, S R Rassekh, et al.
Archives of Women'S Mental Health
|
July 7, 2021
A cross-sectional study of the relationship between CYP2D6 and CYP2C19 variations and depression symptoms, for women taking SSRIs during pregnancy
Catriona Hippman, Caitlin Slomp, Emily Morris, et al.
Human Gene Therapy
|
May 24, 2006
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation
Colin J D Ross, Jaap Twisk, Andrew C Bakker, et al.
Nature Genetics
|
November 10, 2009
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
Colin J D Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2025
Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin Chemotherapy
Joshua Millstein, Shahrad R Rassekh, Austin L Brown, et al.
Gene Therapy
|
March 27, 2025
Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application
Neel Mehta, Rénald Gilbert, Parminder S Chahal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 12, 2026
Liposomal lipid nanoparticles containing dihydrosphingomyelin exhibit improved stability and extended hepatic and extrahepatic transfection
Suiyang Liao, Kevin Fox, Alexandra Birkenshaw, et al.
Canadian Journal of Kidney Health and Disease
|
March 9, 2017
Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study
Kelly R McMahon, Shahrad Rod Rassekh, Kirk R Schultz, et al.
Pediatric Blood & Cancer
|
February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children
H Visscher, C J D Ross, S R Rassekh, et al.
Neurobiology of Disease
|
August 11, 2006
Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma
Braydon L Burgess, Sean A McIsaac, Kathryn E Naus, et al.
Page
of 23